Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

Name: Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies
Published: 2011
License: Public Domain

Atara Biotherapeutics · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

ebv-induced lymphomas, ebv-associated malignancies, transplant patients with ebv viremia at high risk for developing a recurrent ebv lymphoma, ebv-specific t-cell lines, 11-130, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

Related documents